? Expanded (Regional) Pilot and Feasibility Program The specific aim of the Michigan Diabetes Research Center (MDRC) expanded Regional Pilot/Feasibility Study (P/F) Grants Program is to stimulate new research and collaboration in the areas of diabetes, its complications and related endocrine and metabolic disorders in the region. This research may be in areas of basic biomedical science or clinical research. This program will fund at least 2 P/F grants submitted by investigators from our three regional partners per year. A minimum of $100,000 per year will be provided by the MDRC and a minimum of an additional $20,000 per year will be provided through cost-sharing agreements with the University of Toledo, Michigan State University, and Wayne State University. Each year, the MDRC will solicit applications for grants from full-time instructional or research faculty at these three institutions. Those eligible include: 1) new investigators without current or past NIH research support who are beginning careers in diabetes research, 2) established investigators new to diabetes research who wish to focus their expertise on diabetes, and 3) established investigators who propose innovative research in diabetes that represents a clear departure from their ongoing research. Applications are peer-reviewed by at least two extramural investigators with expertise in the area of the application. Those with merit, as judged by this review process and the Grants Program Advisory Council, which includes representatives from the three regional partner universities, will receive P/F awards. The ultimate goal of the grant program is to enhance communication and collaboration among regional diabetes researchers, accelerate the pace of research, and enable awardees to generate sufficient preliminary data for successful applications for major research funding from the NIH or other national granting agencies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020572-44
Application #
10071184
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1996-12-01
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
44
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Bagchi, Devika P; Forss, Isabel; Mandrup, Susanne et al. (2018) SnapShot: Niche Determines Adipocyte Character II. Cell Metab 27:266-266.e1
Arunagiri, Anoop; Haataja, Leena; Cunningham, Corey N et al. (2018) Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes. Ann N Y Acad Sci 1418:5-19
Burgess, Christian R; Livneh, Yoav; Ramesh, Rohan N et al. (2018) Gating of visual processing by physiological need. Curr Opin Neurobiol 49:16-23
Jaiswal, Mamta; Divers, Jasmin; Pop-Busui, Rodica et al. (2018) Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232. Diabetes Care 41:e37
Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne et al. (2018) Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus. PLoS One 13:e0198013
Huang, Wei; Wang, Lu; Li, Jianping et al. (2018) Short-Term Blood Pressure Responses to Ambient Fine Particulate Matter Exposures at the Extremes of Global Air Pollution Concentrations. Am J Hypertens 31:590-599
Zhang, Song-Yang; Dong, Yong-Qiang; Wang, Pengcheng et al. (2018) Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance. EBioMedicine 31:202-216
Ge, Chunxi; Zhao, Guisheng; Li, BinBin et al. (2018) Genetic inhibition of PPAR? S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis. Bone 107:1-9
Peterson, Laura S; Gállego Suárez, Cecilia; Segaloff, Hannah E et al. (2018) Outcomes and Resource Use Among Overweight and Obese Children With Sepsis in the Pediatric Intensive Care Unit. J Intensive Care Med :885066618760541
Hodish, I (2018) Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story. Clin Diabetes Endocrinol 4:8

Showing the most recent 10 out of 1823 publications